The Institute for Regenerative Medicine is based in the Smilow Center for Translational Research and extends across UPenn’s campus.
The links between medicine, engineering and veterinary science differentiate Penn’s Institute for Regenerative Medicine from other stem cell Institutes across the country.
The IRM promotes discoveries in stem cell biology and regeneration to generate new therapies that may alleviate suffering and disease.
When our interdisciplinary research and programs bring together individuals with broad interests and diverse backgrounds, our collaborations lead to greater advances.
Stem cell research is critical to developing new skin tissues and, ultimately, changing the way we care for devastating wounds.
At Penn, we're discovering real possibilities of future treatments for cardiac disease because we have the research and clinical expertise to make it happen.
Institute For Regenerative Medicine
Penn and Rutgers Researchers Discover New Pathway That May Trigger Asthma
Thursday - April 21, 2016
Finding could lead to better drugs for the many asthma patients who don’t respond well to current medications PHILADELPHIA—Asthma is an enormous public health problem that continues to grow larger, in part because scientists don’t…
This spring, the BioEYES program celebrates a major milestone: It will serve its 100,000th student. That means in the 14 years since BioEYES began, 100,000 elementary, middle, and high school students from Philadelphia and four…
Possible ‘Central Hub’ Proteins Found in Cancer Cell Growth
Wednesday - February 10, 2016
A study from researchers at The Children’s Hospital of Philadelphia may add new lines to the textbook description of how cancer cells divide uncontrollably and develop into tumors. Their study, published in Nature Communications, identifies…